IPO
Company Profile
Sanofi is a global biopharmaceutical company developing and manufacturing medicines and vaccines across specialty care, immunology, oncology, and rare diseases.
Founded 1973Paris, FranceSNY
Compare with
vs Tenon Medicalvs Jupiter Neurosciencesvs Ollin Biosciencesvs Assort Healthvs Triveni Biovs Scribe Therapeuticsvs Celea Therapeuticsvs PureTechvs OneMedNetvs Encore Medicalvs Flare Therapeuticsvs AEON Biopharmavs Apnimedvs Shionogivs Drug Farmvs Attovia Therapeuticsvs Chai Discoveryvs Colossal Biosciences
Sanofi FAQ
- Is Sanofi publicly traded?
- Yes. Sanofi trades under the ticker SNY.
Coverage Timeline
newest firstAll Coverage
IPO$128.7M Raised
Scribe Therapeutics Prices Upsized IPO With Sanofi Backing
Gene-editing biotech Scribe Therapeutics priced an upsized IPO at $15 per share, raising $128.7 million with Sanofi as a strategic anchor investor, the first gene-editing IPO in over two years.
IPO
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
IPO$180M+ partnership payments
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
Scribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.